Hebert Biotech Private Limited

Hebert Biotech Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U52601DL2019PTC355342 Incorporated 20 September 2019 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹1.15 Cr
▼ 6% YoY
Net profit · FY 2024
₹1.8 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹3.57 Lakh
EBITDA margin 3.1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Hebert Biotech Private Limited

Data last updated:

Hebert Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 September 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52601DL2019PTC355342. Its GSTIN is 07AAFCH0499E1ZL (Delhi).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It was formerly known as Hebert Bio Private Limited. It is led by directors Siddhant Varshney and Chetan Kumar Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 24 S/F Dsidc Industrial Complex Patparganj, New Delhi, Delhi, India – 110092.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.15 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Lakh (net margin 1.6%) and EBITDA of ₹3.57 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.

The company is associated with 1 brand: Hebert Biotech. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.

For more details, the company can be reached via its website hebertbiotech.com.

Company Details of Hebert Biotech Private Limited
CIN U52601DL2019PTC355342
Registration Number 355342
Incorporation Date 20 September 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Key People
Siddhant Varshney Director Chetan Kumar Gupta Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    hebertbiotech.com
  • Social Media
    Locked
  • Registered Address
    C – 24 S/F Dsidc Industrial Complex Patparganj, New Delhi, Delhi, India – 110092
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Hebert Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Hebert Biotech Private Limited report

Financials, compliance, directors, charges, ownership and filings for Hebert Biotech Private Limited in one report.

Financials from FY 2020 Directors & ownership Charges & compliance

Business Activity of Hebert Biotech Private Limited

The main business activity of Hebert Biotech is manufacturing. In detail, this covers manufacture of food products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturing10Manufacture of food productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Hebert Biotech Private Limited FY 2025 filings available

Hebert Biotech Private Limited reported revenue of ₹1.15 Cr (down 6% YoY) for FY 2024.

Revenue · FY 2024
₹1.15 Cr ▼ 6%
Net profit · FY 2024
₹1.8 Lakh margin 1.6%
EBITDA · FY 2024
₹3.57 Lakh margin 3.1%

Compounded Annual Growth Rate (CAGR) of Hebert Biotech Private Limited

Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 34%

Revenue fell 6% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Hebert Biotech Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹3.57 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.8 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Hebert Biotech Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.1%••••••••••••••••
Net Profit Margin1.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hebert Biotech are in the company report.

Premium access

Financial statements from FY 2020

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Hebert Biotech Private Limited

Hebert Biotech Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of food products). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Jayaleela Bakers and Confectionery Private Limited₹1.17 Cr (FY 2025)••••••••-4.0%••••Mumbai, Maharashtra, India
Ashiyama Healthcare Private Limited₹1.17 Cr (FY 2025)••••••••138.0%••••Mumbai, Maharashtra, India
Brab Food Products Private Limited₹1.17 Cr (FY 2025)••••••••3462.0%••••Purnia, Bihar, India
Polychem Laboratory (India) Private Limited₹1.16 Cr (FY 2025)••••••••-6.0%••••Barasat, West Bengal, India
Hindbake Citadel Private Limited₹1.16 Cr (FY 2025)••••••••472.0%••••Kolhapur, Maharashtra, India
Hebert Biotech Private Limited this company₹1.15 Cr (FY 2024)••••••••-6.0%••••New Delhi, Delhi, India
Mediland Health Care Private Limited₹1.15 Cr (FY 2025)••••••••54.0%••••Kolkata, West Bengal, India
Bijeram Dedraj Oil Mills Pvt. Ltd.₹1.14 Cr (FY 2025)••••••••-8.0%••••Mumbai, Maharashtra, India
Rkswati International Private Limited₹1.14 Cr (FY 2025)••••••••516.0%••••Delhi, India
Grace Dairy Private Limited₹1.13 Cr (FY 2025)••••••••571.0%••••Madhupur, Jharkhand, India
Gladwill Industries Private Limited₹1.13 Cr (FY 2025)••••••••106.0%••••Dadri, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Hebert Biotech by revenue in the same principal business activity (Manufacture of food products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Hebert Biotech Private Limited

Hebert Biotech Private Limited is audited by PMGS & ASSOCIATES for the financial year 2021.

NameStatusAppointment DateCessation Date
PMGS & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Hebert Biotech Private Limited

Hebert Biotech has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Siddhant VarshneyDirector20 Sep 20197 Years 0 MonthsCurrent
Chetan Kumar GuptaDirector20 Sep 20197 Years 0 MonthsCurrent
View all directors

Ownership and Shareholding of Hebert Biotech Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Hebert Biotech Private Limited

Hebert Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Associated Brands with Hebert Biotech Private Limited

Hebert Biotech operates one associated brand: Hebert Biotech. Each brand links to its own profile.

BrandDescriptionWebsite
Hebert Biotech
Development and distribution of pharmaceutical formulations in India.hebertbiotech.com

Employees and EPFO Compliance at Hebert Biotech Private Limited

Employment history and EPFO contributions of people linked to Hebert Biotech.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Hebert Biotech Private Limited

Hebert Biotech Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Chetan Kumar Gupta was appointed as Director on 20 Sep 2019.

AGM
Hebert Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hebert Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Chetan Kumar Gupta was appointed as Director.
Appointed
Siddhant Varshney was appointed as Director.
Incorporation
20 Sep 2019
Hebert Biotech Private Limited was registered on 20 Sep 2019 with Roc Delhi I & aged 7 years 19 days as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Hebert Biotech Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Hebert Biotech Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hebert Biotech Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Hebert Biotech Private Limited

Hebert Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAFCH0499E1ZLDelhiActive17 Jul 2020
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hebert Biotech Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hebert Biotech Private Limited

Hebert Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 September 2019 (7+ years old) and is registered under CIN U52601DL2019PTC355342.

Hebert Biotech reported revenue of ₹1.15 Cr for FY 2024 (down 6% YoY).

Hebert Biotech has 2 current directors:

Hebert Biotech reported a net profit of ₹1.8 Lakh (net margin 1.6%) and EBITDA of ₹3.57 Lakh (EBITDA margin 3.1%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Hebert Biotech is 21% over three years. In the latest year (FY 2024) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Hebert Biotech is 07AAFCH0499E1ZL, registered in Delhi.

The CIN (Corporate Identification Number) of Hebert Biotech is U52601DL2019PTC355342. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hebert Biotech has 1 court case on record: 1 filed by the company. 1 is pending.

Hebert Biotech was incorporated on 20 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Hebert Biotech by revenue are Jayaleela Bakers and Confectionery Private Limited, Ashiyama Healthcare Private Limited, Brab Food Products Private Limited, Polychem Laboratory (India) Private Limited, Hindbake Citadel Private Limited and 5 more, all in the same principal business activity (Manufacture of food products).

Chetan Kumar Gupta was appointed as Director on 20 Sep 2019. Siddhant Varshney was appointed as Director on 20 Sep 2019.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available